FDA Clinical Site Inspections Should Look At Recruitment Tactics - IG Report
This article was originally published in The Tan Sheet
Executive Summary
FDA clinical site inspections should focus on recruitment tactics as well as data integrity, the HHS Office of the Inspector General suggests in a report on clinical trial recruitment released June 12.
You may also be interested in...
IG Clinical Trial Report Stresses Commercial Pressure To Speed Enrollment
The commercial pressures to hasten clinical trial enrollment could be ripe for legislative attention in the context of consideration of bills to improve IRBs.
IG Clinical Trial Report Stresses Commercial Pressure To Speed Enrollment
The commercial pressures to hasten clinical trial enrollment could be ripe for legislative attention in the context of consideration of bills to improve IRBs.
IG Clinical Trial Report Stresses Commercial Pressure To Speed Enrollment
The commercial pressures to hasten clinical trial enrollment could be ripe for legislative attention in the context of consideration of bills to improve IRBs.